Imaging Studies II: Positron Emission Tomography and Scintigraphy

Fluorodeoxyglucose (FDG) is a glucose analog labeled with the radioactive isotope Fluorine-18, serving as the primary tracer in PET imaging. This biologically active molecule allows the scanner to detect metabolic activity by tracking glucose consumption in tissues and organs, making it ideal for diagnosing cancer, neurological disorders, and cardiovascular conditions.

After a radiotracer is injected intravenously, it disperses through the bloodstream and emits positrons. These positrons interact with electrons, producing pairs of gamma photons that travel in opposite directions. The ring-shaped PET scanner detects these gamma photons, and a computer processes the data to reconstruct detailed three-dimensional images showing tracer distribution within the body.

PET reveals metabolic and biochemical functions using fluorodeoxyglucose tracers and detects gamma photons from positron annihilation. Scintigraphy, used primarily for gastrointestinal imaging, labels specific blood cells with radioactive isotopes like Technetium-99m and monitors their distribution over 24-48 hours using gamma cameras to assess organ function and identify pathology.

In scintigraphy, a patient's blood sample is mixed with a radioactive isotope to label specific blood cells, then reinjected into the bloodstream. The labeled cells accumulate in areas of heightened activity, and gamma cameras monitor distribution at intervals like 24 and 48 hours. This reveals gastrointestinal function and highlights potential issues such as masses or inflammation.

Technetium-99m is favored for scintigraphy because of its short half-life of approximately 6 hours, which reduces radiation exposure to patients. It pairs effectively with different compounds to examine various gastrointestinal areas, such as Tc-99m-labeled sulfur colloid for liver-spleen scans and Tc-99m-labeled red blood cells for gastrointestinal bleeding studies.

A nurse inserts an intravenous catheter and injects fluorodeoxyglucose into the patient, who lies supine on a table. After 30-60 minutes, the radiotracer disperses via the bloodstream into organs and tissues. The patient is then placed in the PET scanner, which detects gamma photons and creates images for analysis to diagnose and monitor conditions like cancer and heart disease.

Gamma cameras consist of a detector head with a scintillation crystal that converts gamma rays into light, and photomultiplier tubes that transform and amplify light signals into electrical signals. The gamma camera moves around the patient, capturing images from different angles. A computer then processes these signals to form two-dimensional images representing radioactive tracer distribution. These imaging techniques complement other diagnostic approaches like serum laboratory studies stool test breath test for comprehensive gastrointestinal assessment.